The wearable tech is completely non-invasive and relies on artificial intelligence to find cancerous tumors. So far, the results have been stunning.
When he was 13, he almost lost his mother to breast cancer. And, to makes things worse, the reason why her breast cancer got to stage III was misdiagnosis that allowed the devastating disease to advance. This left a profound impact on Julian Rios, who spent next three years trying to find a way that would enable early diagnosis of breast cancer, and, at age 16, he might have created a product that will save countless lives.
His invention is called EVA, and it’s a wearable device that monitors thermal breast patterns and tissue elasticity, both reliable indicators of early stage breast cancer.
The bra-detector checks for temperature spikes known to be caused by tumors, amongst other things, and shouldn’t be used during exercise. The radial biosensing patches can be placed on any bra, and need to be worn around 90 minutes to collect the data, and this should be done monthly. The information is then sent to an AI-powered app on your phone, alerting both you and your doctor in case the results raise concerns. Out of 15,000 women that already tried this wearable tech, 16 were accurately diagnosed with early-stage breast cancer, giving EVA a stunning score of 89% accuracy.
Únete a nuestra revolución en la detección del cáncer de mama: www.higia.tech & www.evabra.mx. –Join our breast cancer detection revolution: www.higia.tech & www.evabra.mx.
Early detection of breast cancer is crucial: women who find out on time that they have this disease have a 90% chance to have at least a 5-year survival rate, significantly more than 15% estimate for those whose cancer is detected late. Although the timely diagnosis is the key benefit of this AI-powered wearable, EVA has the potential to be significant for younger women as well. As mammogram is not a part of routine exams for women under 40, having an alternative that provides reliable results could be a real game changer. EVA could prevent unnecessary deaths worldwide for women of all ages.
Right now, EVA is being tested through multiple channels to ensure everything is up to standards, but Julian Rios and his team hope their life-saving product will be available to the public by the end of 2018.
Photo credit: SUPREEYA-ANON/Shutterstock